A natural compound extracted from purple sweet potatoes may offer a new way to fight colorectal cancer, according to a recent study. The compound, called Cya-Gly-Fer (CGF), showed strong anti-tumor effects in both laboratory and animal models, significantly slowing tumor growth and reducing liver metastasis, a major cause of death in colorectal cancer patients. Researchers […]

Researchers have developed a new nanomedicine, SH-EM-NP/EPI, aimed at improving treatment for bladder cancer by addressing key limitations of current therapies. In non-muscle-invasive bladder cancer (NMIBC), which accounts for about 75% of cases, recurrence rates remain high—up to 70% within five years—largely because drugs are quickly flushed out of the bladder and struggle to penetrate

A new study has developed the PNI-HB score, a simple blood-based tool to predict outcomes in patients with relapsed or refractory non-Hodgkin lymphoma undergoing CD19 CAR T-cell therapy. Unlike the traditional International Prognostic Index (IPI), the new model focuses on nutritional status and hemoglobin levels, offering a more relevant approach in the immunotherapy era. In

A multicenter study has developed a predictive model to help identify pancreatic cancer patients who are unlikely to benefit from surgery after neoadjuvant therapy. The research focuses on pancreatic ductal adenocarcinoma patients who receive chemotherapy before surgery. Although this approach can improve outcomes, about 24% of patients still experience very poor results after surgery, with

A new mathematical model explains how living systems maintain order and resist disorder. The model views genes as active agents rather than static instructions. They produce enzymes that guide chemical reactions efficiently and steer them toward useful outcomes, helping cells stay organized. It also highlights how proteins consistently fold into precise 3D shapes despite many